Feingold syndrome (also called oculodigitoesophagoduodenal syndrome) is a rare autosomal dominanthereditary disorder. It is named after Murray Feingold, an American physician who first described the syndrome in 1975. Until 2003, at least 79 patients have been reported worldwide.[1]
There is no known treatment for the disorder, but surgery for malformations, special education, and treatment of hearing loss are important.[4]
References
^Tészás A, Meijer R, Scheffer H, et al. (October 2006). "Expanding the clinical spectrum of MYCN-related Feingold syndrome". Am. J. Med. Genet. A. 140 (20): 2254–6. doi:10.1002/ajmg.a.31407. PMID16906565. S2CID6384018.
^Celli J, van Bokhoven H, Brunner HG (November 2003). "Feingold syndrome: clinical review and genetic mapping". Am. J. Med. Genet. A. 122A (4): 294–300. doi:10.1002/ajmg.a.20471. PMID14518066. S2CID38346834.